By Bonnie Eslinger ( November 12, 2020, 5:54 PM GMT) -- Ranbaxy has sued Pfizer-owned Warner-Lambert for lost profits, becoming the latest generic-drug maker to seek damages from the years it couldn't launch a version of the blockbuster drug Lyrica because of a patent that the U.K. Supreme Court later invalidated....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.